Page last updated: 2024-08-23

paroxetine and vilazodone hydrochloride

paroxetine has been researched along with vilazodone hydrochloride in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Bartoszyk, GD; Dawson, LA; Hagan, JJ; Hill, M; Hughes, ZA; Langmead, CJ; Middlemiss, DN; Starr, KR1
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA1
Seyfried, CA; van Amsterdam, C1
Banerjee, P; Chan, JS; Choi, YK; Olivier, B; Oosting, RS; Tarazi, F1
Banerjee, P; Chan, JSW; Olivier, B; Oosting, RS1
Chen, C; Chen, L; Clayton, AH; Durgam, S; Gommoll, CP; Li, D; Mathews, M; Szegedi, A1
Casavant, MJ; Chounthirath, T; Russell, JL; Spiller, HA1
Cole, S; Cyr, N; Eyre, H; Forbes, M; Lavretsky, H; Siddarth, P; Yang, H1
Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V1

Reviews

2 review(s) available for paroxetine and vilazodone hydrochloride

ArticleYear
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Current medicinal chemistry, 2012, Volume: 19, Issue:12

    Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride

2012
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    The Cochrane database of systematic reviews, 2021, 05-24, Volume: 5

    Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine

2021

Trials

2 trial(s) available for paroxetine and vilazodone hydrochloride

ArticleYear
Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study.
    International clinical psychopharmacology, 2017, Volume: 32, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Treatment Outcome; Vilazodone Hydrochloride

2017
Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study.
    Pharmacopsychiatry, 2017, Volume: 50, Issue:6

    Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cyclic AMP Response Element-Binding Protein; Cytokines; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation; Humans; Male; Outcome Assessment, Health Care; Paroxetine; Patient Compliance; Pilot Projects; Psychiatric Status Rating Scales; Transcription Factor AP-1; Vilazodone Hydrochloride

2017

Other Studies

5 other study(ies) available for paroxetine and vilazodone hydrochloride

ArticleYear
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    European journal of pharmacology, 2005, Mar-07, Volume: 510, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzofurans; Benzylamines; Binding, Competitive; Cell Membrane; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Frontal Lobe; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Indoles; Male; Microdialysis; Norepinephrine; Paroxetine; Piperazines; Piperidones; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfur Radioisotopes; Time Factors; Tritium; Vilazodone Hydrochloride

2005
Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    Psychopharmacology, 2014, Volume: 231, Issue:12

    Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Benzofurans; Brain; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluoxetine; Indoles; Male; Paroxetine; Piperazines; Pyridines; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Vilazodone Hydrochloride

2014
Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
    Psychopharmacology, 2016, Volume: 233, Issue:6

    Topics: Animals; Antidepressive Agents; Brain; Citalopram; Male; Paroxetine; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sexual Behavior; Vilazodone Hydrochloride

2016
Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: A role for 5-HT1A receptors?
    Neuropharmacology, 2016, Volume: 107

    Topics: Animals; Drug Administration Schedule; Drug Partial Agonism; Female; Male; Paroxetine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sexual Behavior, Animal; Vilazodone Hydrochloride

2016
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
    Clinical toxicology (Philadelphia, Pa.), 2017, Volume: 55, Issue:5

    Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Paroxetine; Poison Control Centers; Retrospective Studies; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride

2017